Second Death Linked to Potential Antibody Treatment for Alzheimer’s Disease Woman’s brain hemorrhage while receiving Eisai’s widely heralded lecanemab heightens concerns overs its safety
By Charles Piller Global Research, November 30, 2022 Science 27 November 2022 A 65-year-old woman who was receiving a promising experimental treatment to slow the cognitive decline caused by her early Alzheimer’s disease recently died from a massive brain hemorrhage …Source
Related posts:
The next stage of parliamentary life will be the toughest character test Abbott has faced in politic...
Net Harm: Peer-Reviewed Science Shows COVID Injection Harm Outweighs Potential Benefit
Bad news for ISIL & Turkey, Military Convoy, Oil Tankers Destroyed in Syria
Twitter goes wild over reported death penalty for 'atheism' in Saudi Arabia
URGENT: UN Warns 10 Million More Yemenis Expected to Starve to Death by End of Year
Josef Burg -- Jewish Holocaust Denier Visited Death Camps in 1945
Views: 0